logo

The Dermatology Council for England

Login to the members area

Terms of reference          Contact page         @Copyright 2011-2018 Dermatology Council for England

 

The development of this website was kindly sponsored by the British Association of Dermatologists, who have no editorial control over its content.

Please click on the images below to access the latest news and updates on dermatology issues.

bad logo appg logo pcds logo

Update Trimovate availability

 

Trimovate now belongs to Ennogen Healthcare.  It is available through Alliance Specials as an unlicensed special. It is anticipated that a licence will be available in about 4 to 5 months.  Current cost is £54.50 a tube. If there are any problems regarding prescribing then Ennogen say they are happy to receive phone calls. 01322 629220.  Thanks to Fabia at ALSVH for the update.

Parliamentary Questions - Specials

 

Please click on the link below to access a a document that contains a very brief summary of what specials are and some parliamentary questions.

 

Parliamentary Questions-Specials

BDNG Logo

Consultation: "Items which should not routinely be prescribed in primary care: Guidance for CCGs”.

 

A new consultation running for three months from 28 November 2018 is seeking to review and update the original 2017 consultation: “Items which should not routinely be prescribed in primary care: Guidance for CCGs”.

This new commission guidance has added further ‘Low clinical priority’ products that NHS England could be advising CCGs to not routinely prescribe. This includes: bath and shower preparations for dry and pruritic skin conditions; Minocycline for acne; and silk garments for eczema or dermatitis.

During the consultation period a range of events, including face to face events and webinars will be undertaken to gather feedback on the proposals.

 

If you would like to provide feedback to the consultation then details are available here.

 

Psoriasis Association "Top Ten List"

 

2nd November 2018 – The Psoriasis Association 'Top Ten' list, agreed upon by patients, carers and clinicians, marks the culmination of the psoriasis Priority Setting Partnership (PSP).

The Top Ten Psoriasis Research Priorities are:

 

1. Do lifestyle factors such as diet, dietary supplements, alcohol, smoking, weight loss and exercise play a part in treating psoriasis?

 

2. Does treating psoriasis early (or proactively) reduce the severity of the disease, make it more likely to go into remission, or stop other health conditions developing?

 

3. What factors predict how well psoriasis will respond to a treatment?

 

4. What is the best way to treat the symptoms of psoriasis: itching, burning, redness, scaling and flaking?

 

5. How well do psychological and educational interventions work for adults and children with psoriasis?

 

6. Does treating psoriasis help improve other health conditions, such as psoriatic arthritis, cardiovascular disease, metabolic syndrome and stress?

 

7. Why do psoriasis treatments stop working well against psoriasis and when they stop working well, what’s the best way to regain control of the disease?

 

8. To what extent is psoriasis caused by a person’s genes or other factors, such as stress, gut health, water quality, or change in the weather / temperature?

 

9. Is a person with psoriasis more likely to develop other health conditions (either as a consequence of psoriasis or due to the effect of treatments for psoriasis)?  If so, which ones?

 

10. What’s the best way to treat sudden flare ups of psoriasis?